tiprankstipranks
Advertisement
Advertisement

TrueBlue, EHS Reach Cooperation Deal on Board Refresh

Story Highlights
  • TrueBlue and EHS Investments agreed to jointly appoint a new independent director by September 2026, with EHS withdrawing its rival nominations and backing the company’s 2026 slate.
  • Planned director departures and the new EHS-backed appointee will leave TrueBlue with a ten-member board, nine independent, reinforcing governance amid shifting light industrial staffing dynamics.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
TrueBlue, EHS Reach Cooperation Deal on Board Refresh

Claim 30% Off TipRanks

Trueblue ( (TBI) ) has shared an announcement.

On April 10, 2026, TrueBlue entered into a cooperation agreement with EHS Investments under which the company and EHS will mutually select and appoint a new independent director to the board by September 30, 2026, with the director’s term running until the 2027 annual meeting. EHS withdrew its competing director nominations, agreed to support TrueBlue’s slate at the 2026 annual meeting and accepted customary standstill and non-disparagement terms, easing activist pressure and signaling a more collaborative approach to governance.

As part of an ongoing board refresh announced earlier, two directors are expected to step down at or before the 2026 annual meeting, after which the board will comprise ten members, nine of them independent. The agreement, highlighted in an April 13, 2026 press release, is expected to strengthen TrueBlue’s board independence and strategic oversight at a time when investors see recovery potential and growth opportunities in the light industrial staffing industry.

The most recent analyst rating on (TBI) stock is a Buy with a $5.50 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.

Spark’s Take on TBI Stock

According to Spark, TipRanks’ AI Analyst, TBI is a Neutral.

The score is held down primarily by weak financial performance (recent losses and negative operating/free cash flow) and bearish technical trends (below key moving averages with negative MACD). The latest earnings call adds some support via revenue-growth guidance and cost actions, but near-term margin headwinds and reported losses keep the overall outlook constrained; valuation provides limited support given the negative P/E and no dividend data.

To see Spark’s full report on TBI stock, click here.

More about Trueblue

TrueBlue, Inc., listed on the NYSE under the ticker TBI, is a leading provider of specialized workforce solutions spanning flexible staffing, workforce management and recruitment services. Through brands such as PeopleReady, PeopleScout, Staff Management | SMX, Centerline, SIMOS and Healthcare Staffing Professionals, the company serves a broad range of industries via proprietary, digitally enabled platforms.

Average Trading Volume: 313,782

Technical Sentiment Signal: Sell

Current Market Cap: $100.1M

See more data about TBI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1